Botox Cosmetic Injection, Powder, Lyophilized, For Solution
Product Images NDC 0023-9232
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Botox Cosmetic (NDC 0023-9232). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Allergan, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 2 And 3 (Botox 02)
Figure 4: (Botox 03)
Figure 5: Percentage Of Subjects With Treatment Success (% Of Subjects Achieving None Or Mild From Baseline) By Visit (study 1) (Botox 04)
Figure 6: Percentage Of Subjects With Treatment Success (achieving None Or Mild Fhl From Baseline At Maximum Eyebrow Elevation) By Visit (study 1) (Botox 05)
Figure 7: Percentage Of Subjects With Treatment Success (achieving None Or Mild Fhl From Baseline At Maximum Eyebrow Elevation) By Visit (study 2) (Botox 06)
Allergan Horiz Logo (2015) Blk (Botox 08)
Principal Display Panelbotoxcosmeticonabotulinumtoxinafor Injection50units/vial (Botox 09)
Principal Display Panelbotoxcosmeticonabotulinumtoxinafor Injection100units/vial (Botox 0a)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.